These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 81103)

  • 1. Detection of cell-mediated immune reactivity of breast cancer patients by the leukocyte adherence inhibition response to MCF-7 extracts.
    Rudczynski AB; Dyer CA; Mortensen RF
    Cancer Res; 1978 Nov; 38(11 Pt 1):3590-4. PubMed ID: 81103
    [No Abstract]   [Full Text] [Related]  

  • 2. Specificity of the simultaneous cell-mediated immune reactivity to RIII murine mammary tumor virus glycoprotein 55 and human breast cancer tissues.
    Zachrau RE; Black MM; Dion AS; Shore B; Williams CJ; Leis HP
    Cancer Res; 1978 Oct; 38(10):3414-20. PubMed ID: 80264
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of cellular immune response to cancer of the breast.
    Herberman RB
    Ann Clin Lab Sci; 1979; 9(6):467-73. PubMed ID: 229763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte migration inhibition among breast cancer patients in response to various oncogenic viruses.
    Fukuda M; Wanebo HJ; Tsuei L; Ashikari R; Sarkar NH
    J Natl Cancer Inst; 1980 Mar; 64(3):431-7. PubMed ID: 6243720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte migration inhibition response to various antigen preparations of autologous and homologous breast cancer in patients with primary breast cancer.
    Fukuda M; Wanebo HJ; Tsuei L; Sarkar NH
    J Natl Cancer Inst; 1979 Nov; 63(5):1161-9. PubMed ID: 91696
    [No Abstract]   [Full Text] [Related]  

  • 6. Cellular immunity to autologous breast cancer and RIII-murine mammary tumor virus preparations.
    Black MM; Zachrau RE; Shore B; Dion AS; Leis HP
    Cancer Res; 1978 Jul; 38(7):2068-76. PubMed ID: 207421
    [No Abstract]   [Full Text] [Related]  

  • 7. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
    McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J
    J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor immunity in breast cancer patients. Biologic and therapeutic implications.
    Black MM; Zachrau RE
    J Reprod Med; 1979 Jul; 23(1):21-32. PubMed ID: 226697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocyte migration inhibition response to breast cancer antigens and to mouse mammary tumor virus in women with primary breast cancer.
    Fukuda M; Wanebo HJ; Tsuei L; Sarkar NH
    Surg Forum; 1978; 29():167-9. PubMed ID: 233830
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell-mediated immunity to mouse mammary tumor virus antigens by patients with hyperplastic benign breast disease.
    Cannon GB; Barsky SH; Alford TC; Jerome LF; Tinley V; McCoy JL; Dean JH
    J Natl Cancer Inst; 1982 Jun; 68(6):935-43. PubMed ID: 6283226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte migration inhibition responses to MCF-7, murine mammary tumor virus, and Thomsen-Friedenreich antigen in a series of cancer patients.
    Bernhard MI; Wanebo HJ; Helm J; Pace RC; Kaiser DL
    Cancer Res; 1983 Apr; 43(4):1932-7. PubMed ID: 6299532
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes.
    Grosser N; Thomson DM
    Cancer Res; 1975 Sep; 35(9):2571-9. PubMed ID: 1097110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular hypersensitivity of gp55 of RIII-murine mammary tumor virus and gp55-like protein of human breast cancers.
    Black MM; Zachrau RE; Dion AS; Shore B; Fine DL; Leis HP; Williams CJ
    Cancer Res; 1976 Nov; 36(11 Pt 1):4137-42. PubMed ID: 184925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopathology of breast cancer.
    Black MM
    Pathobiol Annu; 1977; 7():213-30. PubMed ID: 201905
    [No Abstract]   [Full Text] [Related]  

  • 15. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
    Halliday WJ; Koppi TA; Khan JM; Davis NC
    J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunodiagnostic aspects of breast cancer. The phenomenon of leukocyte adherence inhibition].
    Fritze D; Fritze J; Kaufmann M; Drings P
    Minerva Med; 1978 Nov; 69(58):3963-7. PubMed ID: 740287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of murine milk samples and human breast tissues on human leukocyte migration indices.
    Black MM; Moore DH; Shore B; Zachrau RE; Leis H
    Cancer Res; 1974 May; 34(5):1054-60. PubMed ID: 4363063
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunological studies in breast cancer. Modifying activity of the serum (MSA).
    Cervantes C; Muzio E; Exposito G; Garcia ME
    Neoplasma; 1980; 27(4):379-86. PubMed ID: 7453855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunology: breast cancer.
    Heppner GH
    Recent Results Cancer Res; 1976; (57):95-108. PubMed ID: 189376
    [No Abstract]   [Full Text] [Related]  

  • 20. Cellular antitumor immune response in women with risk factors for breast cancer.
    Sanner T; Brennhovd I; Christensen I; Jørgensen O; Kvaløy S
    Cancer Res; 1979 Feb; 39(2 Pt 2):654-7. PubMed ID: 761231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.